BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

43 related articles for article (PubMed ID: 12751027)

  • 1. Immunogenicity and tolerance of a 7-valent pneumococcal conjugate vaccine in nonresponders to the 23-valent pneumococcal vaccine.
    Zielen S; Bühring I; Strnad N; Reichenbach J; Hofmann D
    Infect Immun; 2000 Mar; 68(3):1435-40. PubMed ID: 10678957
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multilaboratory evaluation of a viability assay for measurement of opsonophagocytic antibodies specific to the capsular polysaccharides of Streptococcus pneumoniae.
    Romero-Steiner S; Frasch C; Concepcion N; Goldblatt D; Käyhty H; Väkeväinen M; Laferriere C; Wauters D; Nahm MH; Schinsky MF; Plikaytis BD; Carlone GM
    Clin Diagn Lab Immunol; 2003 Nov; 10(6):1019-24. PubMed ID: 14607861
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of multiplex flow cytometric opsonophagocytic assays for determination of functional anticapsular antibodies to Streptococcus pneumoniae.
    Martinez JE; Clutterbuck EA; Li H; Romero-Steiner S; Carlone GM
    Clin Vaccine Immunol; 2006 Apr; 13(4):459-66. PubMed ID: 16603613
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contribution of serotype-specific IgG concentration, IgG subclasses and relative antibody avidity to opsonophagocytic activity against Streptococcus pneumoniae.
    Anttila M; Voutilainen M; Jäntti V; Eskola J; Käyhty H
    Clin Exp Immunol; 1999 Dec; 118(3):402-7. PubMed ID: 10594558
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Validation of a Multiplexed Opsonophagocytic Assay for 11 Additional Pneumococcal Serotypes and Its Application to Functional Antibody Evaluation Induced by Pneumococcal Polysaccharide Vaccine.
    Cha J; Kim HW; Lee JH; Lee S; Kim KH
    J Korean Med Sci; 2018 Dec; 33(51):e340. PubMed ID: 30546285
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of previous vaccination with pneumococcal conjugate vaccine on pneumococcal polysaccharide vaccine antibody responses.
    Schaballie H; Wuyts G; Dillaerts D; Frans G; Moens L; Proesmans M; Vermeulen F; De Boeck K; Meyts I; Bossuyt X
    Clin Exp Immunol; 2016 Aug; 185(2):180-9. PubMed ID: 26939935
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protein carriers of conjugate vaccines: characteristics, development, and clinical trials.
    Pichichero ME
    Hum Vaccin Immunother; 2013 Dec; 9(12):2505-23. PubMed ID: 23955057
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Opsonophagocytic activity following a reduced dose 7-valent pneumococcal conjugate vaccine infant primary series and 23-valent pneumococcal polysaccharide vaccine at 12 months of age.
    Russell FM; Carapetis JR; Burton RL; Lin J; Licciardi PV; Balloch A; Tikoduadua L; Waqatakirewa L; Cheung YB; Tang ML; Nahm MH; Mulholland EK
    Vaccine; 2011 Jan; 29(3):535-44. PubMed ID: 21044669
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional antibodies elicited by two heptavalent pneumococcal conjugate vaccines in the Finnish Otitis Media Vaccine Trial.
    Ekström N; Väkeväinen M; Verho J; Kilpi T; Käyhty H
    Infect Immun; 2007 Apr; 75(4):1794-800. PubMed ID: 17261612
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pneumococcal capsular polysaccharide vaccine-mediated protection against serotype 3 Streptococcus pneumoniae in immunodeficient mice.
    Tian H; Groner A; Boes M; Pirofski LA
    Infect Immun; 2007 Apr; 75(4):1643-50. PubMed ID: 17220309
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Priming of immunological memory by pneumococcal conjugate vaccine in children unresponsive to 23-valent polysaccharide pneumococcal vaccine.
    Rose MA; Schubert R; Strnad N; Zielen S
    Clin Diagn Lab Immunol; 2005 Oct; 12(10):1216-22. PubMed ID: 16210486
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Approach to validating an opsonophagocytic assay for Streptococcus pneumoniae.
    Hu BT; Yu X; Jones TR; Kirch C; Harris S; Hildreth SW; Madore DV; Quataert SA
    Clin Diagn Lab Immunol; 2005 Feb; 12(2):287-95. PubMed ID: 15699424
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kinetics and avidity of antibodies evoked by heptavalent pneumococcal conjugate vaccines PncCRM and PncOMPC in the Finnish Otitis Media Vaccine Trial.
    Ekström N; Ahman H; Verho J; Jokinen J; Väkeväinen M; Kilpi T; Käyhty H
    Infect Immun; 2005 Jan; 73(1):369-77. PubMed ID: 15618174
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional antibodies elicited by an 11-valent diphtheria-tetanus toxoid-conjugated pneumococcal vaccine.
    Puumalainen T; Ekström N; Zeta-Capeding R; Ollgren J; Jousimies K; Lucero M; Nohynek H; Käyhty H
    J Infect Dis; 2003 Jun; 187(11):1704-8. PubMed ID: 12751027
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Similar antibody concentrations in Filipino infants at age 9 months, after 1 or 3 doses of an adjuvanted, 11-valent pneumococcal diphtheria/tetanus-conjugated vaccine: a randomized controlled trial.
    Lucero MG; Puumalainen T; Ugpo JM; Williams G; Käyhty H; Nohynek H
    J Infect Dis; 2004 Jun; 189(11):2077-84. PubMed ID: 15143476
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Avidity and subclasses of IgG after immunization of infants with an 11-valent pneumococcal conjugate vaccine with or without aluminum adjuvant.
    Wuorimaa T; Dagan R; Väkeväinen M; Bailleux F; Haikala R; Yaich M; Eskola J; Käyhty H
    J Infect Dis; 2001 Nov; 184(9):1211-5. PubMed ID: 11598848
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tolerability and immunogenicity of an eleven valent mixed carrier Streptococcus pneumoniae capsular polysaccharide-diphtheria toxoid or tetanus protein conjugate vaccine in Finnish and Israeli infants.
    Dagan R; Kayhty H; Wuorimaa T; Yaich M; Bailleux F; Zamir O; Eskola J
    Pediatr Infect Dis J; 2004 Feb; 23(2):91-8. PubMed ID: 14872172
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pneumococcal polysaccharide protein D-conjugate vaccine (Synflorix; PHiD-CV).
    Croxtall JD; Keating GM
    Paediatr Drugs; 2009; 11(5):349-57. PubMed ID: 19725600
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunogenicity of routinely used childhood vaccines when coadministered with the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV).
    Knuf M; Szenborn L; Moro M; Petit C; Bermal N; Bernard L; Dieussaert I; Schuerman L
    Pediatr Infect Dis J; 2009 Apr; 28(4 Suppl):S97-S108. PubMed ID: 19325452
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.